Global Erectile Dysfunction Drugs Market By Product Type (Branded Drugs (Viagra, Cialis, Zydena, and Others) and Generic Drugs (Sildenafil, Tadalafil, Vardenafil, Alprostadil, and Others)), By Route of Administration (Oral, Injectable, Topical and Intraurethral Suppositories), By Distribution Channel (Hospital Pharmacies and Retail Pharmacies), Region and Companies – Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2025-2034

Table of Contents

• 1. Executive Summary
  • 1.1. Definition
  • 1.2. Market Snapshot
  • 1.3. Market Overview
  • 1.4. Segment Overview
  • 1.5. Regional Overview
  • 1.6. Competitive Landscape
  • 1.7. Taxonomy
• 2. Global Market Overview
  • 2.1. Global Market Insights and Industry Overview
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
      • 2.2.1.1. Increasing Prevalence of Erectile Dysfunction
    • 2.2.2. Restraints
      • 2.2.2.1. Side Effects and Contraindications
    • 2.2.3. Opportunities
      • 2.2.3.1. New Drug Formulations and Delivery Methods
    • 2.2.4. Key Erectile Dysfunction Drugs Market Trends
  • 2.3. Regulatory Framework
  • 2.4. Opportunity Map Analysis
  • 2.5. Opportunity Orbits
  • 2.6. PESTLE Analysis
  • 2.7. PORTER’S Five Force Analysis
  • 2.8. Drivers & Restraints Impact Analysis
  • 2.9. Value Chain Analysis
    • 2.9.1. List of Raw Materials Suppliers
    • 2.9.2. List of Erectile Dysfunction Drugs Manufacturers
    • 2.9.3. List of Dealer/Distributors
  • 2.10. Regional Market Share and BPS Analysis
  • 2.11. Impact of Macro-economic Factors/Geopolitical Factors
• 3. Global Erectile Dysfunction Drugs Market Analysis and Forecast, By Segment, 2020-2034
  • 3.1. Key Findings
  • 3.2. Global Erectile Dysfunction Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 3.3. Global Erectile Dysfunction Drugs Market Attractiveness Analysis, By Product Type
    • 3.3.1. Branded Drugs
      • 3.3.1.1. Insights
      • 3.3.1.2. Key Takeaways
    • 3.3.2. Generic Drugs
      • 3.3.2.1. Insights
      • 3.3.2.2. Key Takeaways
  • 3.4. Global Erectile Dysfunction Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
  • 3.5. Global Erectile Dysfunction Drugs Market Attractiveness Analysis, By Route of Administration
    • 3.5.1. Oral
      • 3.5.1.1. Insights
      • 3.5.1.2. Key Takeaways
    • 3.5.2. Injectable
      • 3.5.2.1. Insights
      • 3.5.2.2. Key Takeaways
    • 3.5.3. Topical
      • 3.5.3.1. Insights
      • 3.5.3.2. Key Takeaways
    • 3.5.4. Intraurethral Suppositories
      • 3.5.4.1. Insights
      • 3.5.4.2. Key Takeaways
  • 3.6. Global Erectile Dysfunction Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  • 3.7. Global Erectile Dysfunction Drugs Market Attractiveness Analysis, By Distribution Channel
    • 3.7.1. Hospital Pharmacies
      • • 3.7.1.1. Insights
        • 3.7.1.2. Key Takeaways
    • 3.7.2. Retail Pharmacies
      • 3.7.2.1. Insights
      • 3.7.2.2. Key Takeaways
    • 3.7.3. Online Pharmacies
      • 3.7.3.1. Insights
      • 3.7.3.2. Key Takeaways
• 4. Global Erectile Dysfunction Drugs Market Analysis and Forecast, By Region, 2020-2034
  • 4.1. Key Findings
  • 4.2. Global Erectile Dysfunction Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Region, 2020-2034
    • 4.2.1. North America
      • 4.2.1.1. Regional Insights
    • 4.2.2. Europe
      • 4.2.2.1. Regional Insights
    • 4.2.3. Asia Pacific
      • 4.2.3.1. Regional Insights
    • 4.2.4. Latin America
      • 4.2.4.1. Regional Insights
    • 4.2.5. Middle East & Africa
      • 4.2.5.1. Regional Insights
  • 4.3. Global Erectile Dysfunction Drugs Market Attractiveness Analysis, By Region
• 5. North America Erectile Dysfunction Drugs Market Analysis and Forecast, 2020-2034
  • 5.1. Key Findings
  • 5.2. North America Erectile Dysfunction Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 5.3. North America Erectile Dysfunction Drugs Market Attractiveness Analysis, By Product Type
  • 5.4. North America Erectile Dysfunction Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
  • 5.5. North America Erectile Dysfunction Drugs Market Attractiveness Analysis, By Route of Administration
  • 5.6. North America Erectile Dysfunction Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  • 5.7. North America Erectile Dysfunction Drugs Market Attractiveness Analysis, By Distribution Channel
  • 5.8. North America Erectile Dysfunction Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 5.9. North America Erectile Dysfunction Drugs Market Attractiveness Analysis, By Country
    • 5.9.1. The US
    • 5.9.2. Canada
• 6. Europe Erectile Dysfunction Drugs Market Analysis and Forecast, 2020-2034
  • 6.1. Key Findings
  • 6.2. Europe Erectile Dysfunction Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 6.3. Europe Erectile Dysfunction Drugs Market Attractiveness Analysis, By Product Type
  • 6.4. Europe Erectile Dysfunction Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
  • 6.5. Europe Erectile Dysfunction Drugs Market Attractiveness Analysis, By Route of Administration
  • 6.6. Europe Erectile Dysfunction Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  • 6.7. Europe Erectile Dysfunction Drugs Market Attractiveness Analysis, By Distribution Channel
  • 6.8. Europe Erectile Dysfunction Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 6.9. Europe Erectile Dysfunction Drugs Market Attractiveness Analysis, By Country
    • 6.9.1. Germany
    • 6.9.2. The UK
    • 6.9.3. France
    • 6.9.4. Spain
    • 6.9.5. Italy
    • 6.9.6. Russia
    • 6.9.7. Netherland
    • 6.9.8. Rest of Europe
• 7. Asia Pacific Erectile Dysfunction Drugs Market Analysis and Forecast, 2020-2034
  • 7.1. Key Findings
  • 7.2. Asia Pacific Erectile Dysfunction Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 7.3. Asia Pacific Erectile Dysfunction Drugs Market Attractiveness Analysis, By Product Type
  • 7.4. Asia Pacific Erectile Dysfunction Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
  • 7.5. Asia Pacific Erectile Dysfunction Drugs Market Attractiveness Analysis, By Route of Administration
  • 7.6. Asia Pacific Erectile Dysfunction Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  • 7.7. Asia Pacific Erectile Dysfunction Drugs Market Attractiveness Analysis, By Distribution Channel
  • 7.8. Asia Pacific Erectile Dysfunction Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 7.9. Asia Pacific Erectile Dysfunction Drugs Market Attractiveness Analysis, By Country
    • 7.9.1. China
    • 7.9.2. Japan
    • 7.9.3. South Korea
    • 7.9.4. India
    • 7.9.5. Australia
    • 7.9.6. New Zealand
    • 7.9.7. Singapore
    • 7.9.8. Thailand
    • 7.9.9. Vietnam
    • 7.9.10. Rest of Asia Pacific
• 8. Latin America Erectile Dysfunction Drugs Market Analysis and Forecast, 2020-2034
  • 8.1. Key Findings
  • 8.2. Latin America Erectile Dysfunction Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 8.3. Latin America Erectile Dysfunction Drugs Market Attractiveness Analysis, By Product Type
  • 8.4. Latin America Erectile Dysfunction Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
  • 8.5. Latin America Erectile Dysfunction Drugs Market Attractiveness Analysis, By Route of Administration
  • 8.6. Latin America Erectile Dysfunction Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  • 8.7. Latin America Erectile Dysfunction Drugs Market Attractiveness Analysis, By Distribution Channel
  • 8.8. Latin America Erectile Dysfunction Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 8.9. Latin America Erectile Dysfunction Drugs Market Attractiveness Analysis, By Country
    • 8.9.1. Brazil
    • 8.9.2. Mexico
    • 8.9.3. Rest of Latin America
• 9. Middle East & Africa Erectile Dysfunction Drugs Market Analysis and Forecast, 2020-2034
  • 9.1. Key Findings
  • 9.2. Middle East & Africa Erectile Dysfunction Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Product Type, 2020-2034
  • 9.3. Middle East & Africa Erectile Dysfunction Drugs Market Attractiveness Analysis, By Product Type
  • 9.4. Middle East & Africa Erectile Dysfunction Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Route of Administration, 2020-2034
  • 9.5. Middle East & Africa Erectile Dysfunction Drugs Market Attractiveness Analysis, By Route of Administration
  • 9.6. Middle East & Africa Erectile Dysfunction Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Distribution Channel, 2020-2034
  • 9.7. Middle East & Africa Erectile Dysfunction Drugs Market Attractiveness Analysis, By Distribution Channel
  • 9.8. Middle East & Africa Erectile Dysfunction Drugs Market Size Value (US$ Mn) Analysis, Opportunity and Forecast, By Country, 2020-2034
  • 9.9. Middle East & Africa Erectile Dysfunction Drugs Market Attractiveness Analysis, By Country
    • 9.9.1. South Africa
    • 9.9.2. Saudi Arabia
    • 9.9.3. UAE
    • 9.9.4. Rest of Middle East & Africa
• 10. Competitive Landscape & Company Profiles
  • 10.1. Market Competition Scenario Analysis, By Company
    • 10.1.1. Key Takeaways
  • 10.2. Overview of Major Market Players
  • 10.3. Competitor Landscape
  • 10.4. Strategic Mapping
  • 10.5. Company Life Cycle Analysis
  • 10.6. Company Market Share Analysis
  • 10.7. Company Profiles
    • 10.7.1. Novartis AG
      • 10.7.1.1. Company Details
      • 10.7.1.2. Business Overview
      • 10.7.1.3. Product Portfolio
      • 10.7.1.4. Financial Insights
      • 10.7.1.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.1.6. SWOT Analysis
      • 10.7.1.7. Geographic Footprint
    • 10.7.2. Eli Lilly and Company
      • • 10.7.2.1. Company Details
        • 10.7.2.2. Business Overview
        • 10.7.2.3. Product Portfolio
        • 10.7.2.4. Financial Insights
        • 10.7.2.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
        • 10.7.2.6. SWOT Analysis
        • 10.7.2.7. Geographic Footprint
    • 10.7.3. Pfizer Inc.
      • 10.7.3.1. Company Details
      • 10.7.3.2. Business Overview
      • 10.7.3.3. Product Portfolio
      • 10.7.3.4. Financial Insights
      • 10.7.3.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.3.6. SWOT Analysis
      • 10.7.3.7. Geographic Footprint
    • 10.7.4. Viatris Inc.
      • 10.7.4.1. Company Details
      • 10.7.4.2. Business Overview
      • 10.7.4.3. Product Portfolio
      • 10.7.4.4. Financial Insights
      • 10.7.4.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.4.6. SWOT Analysis
      • 10.7.4.7. Geographic Footprint
    • 10.7.5. Teva Pharmaceutical Industries Ltd.
      • 10.7.5.1. Company Details
      • 10.7.5.2. Business Overview
      • 10.7.5.3. Product Portfolio
      • 10.7.5.4. Financial Insights
      • 10.7.5.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.5.6. SWOT Analysis
      • 10.7.5.7. Geographic Footprint
    • 10.7.6. Sun Pharmaceutical Industries Ltd.
      • 10.7.6.1. Company Details
      • 10.7.6.2. Business Overview
      • 10.7.6.3. Product Portfolio
      • 10.7.6.4. Financial Insights
      • 10.7.6.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.6.6. SWOT Analysis
      • 10.7.6.7. Geographic Footprint
    • 10.7.7. Aurobindo Pharma Limited
      • 10.7.7.1. Company Details
      • 10.7.7.2. Business Overview
      • 10.7.7.3. Product Portfolio
      • 10.7.7.4. Financial Insights
      • 10.7.7.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.7.6. SWOT Analysis
      • 10.7.7.7. Geographic Footprint
    • 10.7.8. Glenmark Pharmaceuticals
      • 10.7.8.1. Company Details
      • 10.7.8.2. Business Overview
      • 10.7.8.3. Product Portfolio
      • 10.7.8.4. Financial Insights
      • 10.7.8.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.8.6. SWOT Analysis
      • 10.7.8.7. Geographic Footprint
    • 10.7.9. Torrent Pharmaceuticals Ltd.
      • 10.7.9.1. Company Details
      • 10.7.9.2. Business Overview
      • 10.7.9.3. Product Portfolio
      • 10.7.9.4. Financial Insights
      • 10.7.9.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.9.6. SWOT Analysis
      • 10.7.9.7. Geographic Footprint
    • 10.7.10. Accord Healthcare Inc.
      • 10.7.10.1. Company Details
      • 10.7.10.2. Business Overview
      • 10.7.10.3. Product Portfolio
      • 10.7.10.4. Financial Insights
      • 10.7.10.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.10.6. SWOT Analysis
      • 10.7.10.7. Geographic Footprint
    • 10.7.11. CURE Pharmaceutical
      • 10.7.11.1. Company Details
      • 10.7.11.2. Business Overview
      • 10.7.11.3. Product Portfolio
      • 10.7.11.4. Financial Insights
      • 10.7.11.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.11.6. SWOT Analysis
      • 10.7.11.7. Geographic Footprint
    • 10.7.12. Adamed
      • 10.7.12.1. Company Details
      • 10.7.12.2. Business Overview
      • 10.7.12.3. Product Portfolio
      • 10.7.12.4. Financial Insights
      • 10.7.12.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.12.6. SWOT Analysis
      • 10.7.12.7. Geographic Footprint
    • 10.7.13. Aspargo Laboratories, Inc.
      • 10.7.13.1. Company Details
      • 10.7.13.2. Business Overview
      • 10.7.13.3. Product Portfolio
      • 10.7.13.4. Financial Insights
      • 10.7.13.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.13.6. SWOT Analysis
      • 10.7.13.7. Geographic Footprint
    • 10.7.14. Dong-A Pharmaceutical Co., Ltd
      • 10.7.14.1. Company Details
      • 10.7.14.2. Business Overview
      • 10.7.14.3. Product Portfolio
      • 10.7.14.4. Financial Insights
      • 10.7.14.5. Key Developments (Investments & Expansions, Merger & Acquisition, Partnership & Agreement and New Product Development)
      • 10.7.14.6. SWOT Analysis
      • 10.7.14.7. Geographic Footprint
• 11. Methodology and Data Source
  • 11.1. Methodology/Research Approach
  • 11.2. Market Size Estimation
  • 11.3. Market Breakdown and Data Triangulation
  • 11.4. Data Source
  • 11.5. Secondary Sources
  • 11.6. Primary Sources
  • 11.7. Appendix
  • 11.8. Disclaimer

List of Tables

• Table 1. Global Erectile Dysfunction Drugs Market Value (US$ Mn), By Product Type, 2020-2034
• Table 2. Global Erectile Dysfunction Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 3. Global Erectile Dysfunction Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 4. Global Erectile Dysfunction Drugs Market Value (US$ Mn), By Region, 2020-2034
• Table 5. North America Erectile Dysfunction Drugs Market Value (US$ Mn), By Product Type, 2020-2034
• Table 6. North America Erectile Dysfunction Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 7. North America Erectile Dysfunction Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 8. North America Erectile Dysfunction Drugs Market Value (US$ Mn), By Country, 2020-2034
• Table 9. The US Erectile Dysfunction Drugs Market Value (US$ Mn), By Product Type, 2020-2034
• Table 10. The US Erectile Dysfunction Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 11. The US Erectile Dysfunction Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 12. Canada Erectile Dysfunction Drugs Market Value (US$ Mn), By Product Type, 2020-2034
• Table 13. Canada Erectile Dysfunction Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 14. Canada Erectile Dysfunction Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 15. Europe Erectile Dysfunction Drugs Market Value (US$ Mn), By Product Type, 2020-2034
• Table 16. Europe Erectile Dysfunction Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 17. Europe Erectile Dysfunction Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 18. Europe Erectile Dysfunction Drugs Market Value (US$ Mn), By Country, 2020-2034
• Table 19. Germany Erectile Dysfunction Drugs Market Value (US$ Mn), By Product Type, 2020-2034
• Table 20. Germany Erectile Dysfunction Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 21. Germany Erectile Dysfunction Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 22. The UK Erectile Dysfunction Drugs Market Value (US$ Mn), By Product Type, 2020-2034
• Table 23. The UK Erectile Dysfunction Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 24. The UK Erectile Dysfunction Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 25. France Erectile Dysfunction Drugs Market Value (US$ Mn), By Product Type, 2020-2034
• Table 26. France Erectile Dysfunction Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 27. France Erectile Dysfunction Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 28. Spain Erectile Dysfunction Drugs Market Value (US$ Mn), By Product Type, 2020-2034
• Table 29. Spain Erectile Dysfunction Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 30. Spain Erectile Dysfunction Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 31. Italy Erectile Dysfunction Drugs Market Value (US$ Mn), By Product Type, 2020-2034
• Table 32. Italy Erectile Dysfunction Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 33. Italy Erectile Dysfunction Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 34. Russia Erectile Dysfunction Drugs Market Value (US$ Mn), By Product Type, 2020-2034
• Table 35. Russia Erectile Dysfunction Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 36. Russia Erectile Dysfunction Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 37. Netherland Erectile Dysfunction Drugs Market Value (US$ Mn), By Product Type, 2020-2034
• Table 38. Netherland Erectile Dysfunction Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 39. Netherland Erectile Dysfunction Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 40. Rest of Europe Erectile Dysfunction Drugs Market Value (US$ Mn), By Product Type, 2020-2034
• Table 41. Rest of Europe Erectile Dysfunction Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 42. Rest of Europe Erectile Dysfunction Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 43. Asia Pacific Erectile Dysfunction Drugs Market Value (US$ Mn), By Product Type, 2020-2034
• Table 44. Asia Pacific Erectile Dysfunction Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 45. Asia Pacific Erectile Dysfunction Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 46. Asia Pacific Erectile Dysfunction Drugs Market Value (US$ Mn), By Country, 2020-2034
• Table 47. China Erectile Dysfunction Drugs Market Value (US$ Mn), By Product Type, 2020-2034
• Table 48. China Erectile Dysfunction Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 49. China Erectile Dysfunction Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 50. India Erectile Dysfunction Drugs Market Value (US$ Mn), By Product Type, 2020-2034
• Table 51. India Erectile Dysfunction Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 52. India Erectile Dysfunction Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 53. Japan Erectile Dysfunction Drugs Market Value (US$ Mn), By Product Type, 2020-2034
• Table 54. Japan Erectile Dysfunction Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 55. Japan Erectile Dysfunction Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 56. South Korea Erectile Dysfunction Drugs Market Value (US$ Mn), By Product Type, 2020-2034
• Table 57. South Korea Erectile Dysfunction Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 58. South Korea Erectile Dysfunction Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 59. Australia Erectile Dysfunction Drugs Market Value (US$ Mn), By Product Type, 2020-2034
• Table 60. Australia Erectile Dysfunction Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 61. Australia Erectile Dysfunction Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 62. New Zealand Erectile Dysfunction Drugs Market Value (US$ Mn), By Product Type, 2020-2034
• Table 63. New Zealand Erectile Dysfunction Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 64. New Zealand Erectile Dysfunction Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 65. Singapore Erectile Dysfunction Drugs Market Value (US$ Mn), By Product Type, 2020-2034
• Table 66. Singapore Erectile Dysfunction Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 67. Singapore Erectile Dysfunction Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 68. Thailand Erectile Dysfunction Drugs Market Value (US$ Mn), By Product Type, 2020-2034
• Table 69. Thailand Erectile Dysfunction Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 70. Thailand Erectile Dysfunction Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 71. Vietnam Erectile Dysfunction Drugs Market Value (US$ Mn), By Product Type, 2020-2034
• Table 72. Vietnam Erectile Dysfunction Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 73. Vietnam Erectile Dysfunction Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 74. Rest of Asia Pacific Erectile Dysfunction Drugs Market Value (US$ Mn), By Product Type, 2020-2034
• Table 75. Rest of Asia Pacific Erectile Dysfunction Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 76. Rest of Asia Pacific Erectile Dysfunction Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 77. Latin America Erectile Dysfunction Drugs Market Value (US$ Mn), By Product Type, 2020-2034
• Table 78. Latin America Erectile Dysfunction Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 79. Latin America Erectile Dysfunction Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 80. Latin America Erectile Dysfunction Drugs Market Value (US$ Mn), By Country, 2020-2034
• Table 81. Brazil Erectile Dysfunction Drugs Market Value (US$ Mn), By Product Type, 2020-2034
• Table 82. Brazil Erectile Dysfunction Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 83. Brazil Erectile Dysfunction Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 84. Mexico Erectile Dysfunction Drugs Market Value (US$ Mn), By Product Type, 2020-2034
• Table 85. Mexico Erectile Dysfunction Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 86. Mexico Erectile Dysfunction Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 87. Rest of Latin America Erectile Dysfunction Drugs Market Value (US$ Mn), By Product Type, 2020-2034
• Table 88. Rest of Latin America Erectile Dysfunction Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 89. Rest of Latin America Erectile Dysfunction Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 90. Middle East & Africa Erectile Dysfunction Drugs Market Value (US$ Mn), By Product Type, 2020-2034
• Table 91. Middle East & Africa Erectile Dysfunction Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 92. Middle East & Africa Erectile Dysfunction Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 93. Middle East & Africa Erectile Dysfunction Drugs Market Value (US$ Mn), By Country, 2020-2034
• Table 94. South Africa Erectile Dysfunction Drugs Market Value (US$ Mn), By Product Type, 2020-2034
• Table 95. South Africa Erectile Dysfunction Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 96. South Africa Erectile Dysfunction Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 97. Saudi Arabia Erectile Dysfunction Drugs Market Value (US$ Mn), By Product Type, 2020-2034
• Table 98. Saudi Arabia Erectile Dysfunction Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 99. Saudi Arabia Erectile Dysfunction Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 100. UAE Erectile Dysfunction Drugs Market Value (US$ Mn), By Product Type, 2020-2034
• Table 101. UAE Erectile Dysfunction Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 102. UAE Erectile Dysfunction Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034
• Table 103. Rest of Middle East & Africa Erectile Dysfunction Drugs Market Value (US$ Mn), By Product Type, 2020-2034
• Table 104. Rest of Middle East & Africa Erectile Dysfunction Drugs Market Value (US$ Mn), By Route of Administration, 2020-2034
• Table 105. Rest of Middle East & Africa Erectile Dysfunction Drugs Market Value (US$ Mn), By Distribution Channel, 2020-2034

List of Figures

• Figure 1. Global Erectile Dysfunction Drugs Market Snapshot: Market Value (US$ Mn), 2020-2034
• Figure 2. Opportunity Map
• Figure 3. Opportunity Orbit
• Figure 4. Regional Market Share and BPS Analysis in Erectile Dysfunction Drugs Market
• Figure 5. Global Erectile Dysfunction Drugs Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 6. Global Erectile Dysfunction Drugs Market Attractiveness Analysis, By Product Type
• Figure 7. Global Erectile Dysfunction Drugs Market Analysis, By Route of Administration, 2020, 2024 and 2034
• Figure 8. Global Erectile Dysfunction Drugs Market Attractiveness Analysis, By Route of Administration
• Figure 9. Global Erectile Dysfunction Drugs Market Analysis, By Distribution Channel, 2020, 2024 and 2034
• Figure 10. Global Erectile Dysfunction Drugs Market Attractiveness Analysis, By Distribution Channel
• Figure 11. Global Erectile Dysfunction Drugs Market Analysis, By Region, 2020, 2024 and 2034
• Figure 12. Global Erectile Dysfunction Drugs Market Attractiveness Analysis, By Region
• Figure 13. North America Erectile Dysfunction Drugs Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 14. North America Erectile Dysfunction Drugs Market Attractiveness Analysis, By Product Type
• Figure 15. North America Erectile Dysfunction Drugs Market (US$ Mn), by Branded Drugs, 2020-2034
• Figure 16. North America Erectile Dysfunction Drugs Market (US$ Mn), by Generic Drugs, 2020-2034
• Figure 17. North America Erectile Dysfunction Drugs Market Analysis, By Route of Administration, 2020, 2024 and 2034
• Figure 18. North America Erectile Dysfunction Drugs Market Attractiveness Analysis, By Route of Administration
• Figure 19. North America Erectile Dysfunction Drugs Market (US$ Mn), by Oral, 2020-2034
• Figure 20. North America Erectile Dysfunction Drugs Market (US$ Mn), by Injectable, 2020-2034
• Figure 21. North America Erectile Dysfunction Drugs Market (US$ Mn), by Topical, 2020-2034
• Figure 22. North America Erectile Dysfunction Drugs Market (US$ Mn), by Intraurethral Suppositories, 2020-2034
• Figure 23. North America Erectile Dysfunction Drugs Market Analysis, By Distribution Channel, 2020, 2024 and 2034
• Figure 24. North America Erectile Dysfunction Drugs Market Attractiveness Analysis, By Distribution Channel
• Figure 25. North America Erectile Dysfunction Drugs Market (US$ Mn), by Hospital Pharmacies, 2020-2034
• Figure 26. North America Erectile Dysfunction Drugs Market (US$ Mn), by Retail Pharmacies, 2020-2034
• Figure 27. North America Erectile Dysfunction Drugs Market (US$ Mn), by Online Pharmacies, 2020-2034
• Figure 28. North America Erectile Dysfunction Drugs Market Analysis, By Country, 2020, 2024 and 2034
• Figure 29. North America Erectile Dysfunction Drugs Market Attractiveness Analysis, By Country
• Figure 30. Europe Erectile Dysfunction Drugs Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 31. Europe Erectile Dysfunction Drugs Market Attractiveness Analysis, By Product Type
• Figure 32. Europe Erectile Dysfunction Drugs Market (US$ Mn), by Branded Drugs, 2020-2034
• Figure 33. Europe Erectile Dysfunction Drugs Market (US$ Mn), by Generic Drugs, 2020-2034
• Figure 34. Europe Erectile Dysfunction Drugs Market Analysis, By Route of Administration, 2020, 2024 and 2034
• Figure 35. Europe Erectile Dysfunction Drugs Market Attractiveness Analysis, By Route of Administration
• Figure 36. Europe Erectile Dysfunction Drugs Market (US$ Mn), by Oral, 2020-2034
• Figure 37. Europe Erectile Dysfunction Drugs Market (US$ Mn), by Injectable, 2020-2034
• Figure 38. Europe Erectile Dysfunction Drugs Market (US$ Mn), by Topical, 2020-2034
• Figure 39. Europe Erectile Dysfunction Drugs Market (US$ Mn), by Intraurethral Suppositories, 2020-2034
• Figure 40. Europe Erectile Dysfunction Drugs Market Analysis, By Distribution Channel, 2020, 2024 and 2034
• Figure 41. Europe Erectile Dysfunction Drugs Market Attractiveness Analysis, By Distribution Channel
• Figure 42. Europe Erectile Dysfunction Drugs Market (US$ Mn), by Hospital Pharmacies, 2020-2034
• Figure 43. Europe Erectile Dysfunction Drugs Market (US$ Mn), by Retail Pharmacies, 2020-2034
• Figure 44. Europe Erectile Dysfunction Drugs Market (US$ Mn), by Online Pharmacies, 2020-2034
• Figure 45. Europe Erectile Dysfunction Drugs Market Analysis, By Country, 2020, 2024 and 2034
• Figure 46. Europe Erectile Dysfunction Drugs Market Attractiveness Analysis, By Country
• Figure 47. Asia Pacific Erectile Dysfunction Drugs Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 48. Asia Pacific Erectile Dysfunction Drugs Market Attractiveness Analysis, By Product Type
• Figure 49. Asia Pacific Erectile Dysfunction Drugs Market (US$ Mn), by Branded Drugs, 2020-2034
• Figure 50. Asia Pacific Erectile Dysfunction Drugs Market (US$ Mn), by Generic Drugs, 2020-2034
• Figure 51. Asia Pacific Erectile Dysfunction Drugs Market Analysis, By Route of Administration, 2020, 2024 and 2034
• Figure 52. Asia Pacific Erectile Dysfunction Drugs Market Attractiveness Analysis, By Route of Administration
• Figure 53. Asia Pacific Erectile Dysfunction Drugs Market (US$ Mn), by Oral, 2020-2034
• Figure 54. Asia Pacific Erectile Dysfunction Drugs Market (US$ Mn), by Injectable, 2020-2034
• Figure 55. Asia Pacific Erectile Dysfunction Drugs Market (US$ Mn), by Topical, 2020-2034
• Figure 56. Asia Pacific Erectile Dysfunction Drugs Market (US$ Mn), by Intraurethral Suppositories, 2020-2034
• Figure 57. Asia Pacific Erectile Dysfunction Drugs Market Analysis, By Distribution Channel, 2020, 2024 and 2034
• Figure 58. Asia Pacific Erectile Dysfunction Drugs Market Attractiveness Analysis, By Distribution Channel
• Figure 59. Asia Pacific Erectile Dysfunction Drugs Market (US$ Mn), by Hospital Pharmacies, 2020-2034
• Figure 60. Asia Pacific Erectile Dysfunction Drugs Market (US$ Mn), by Retail Pharmacies, 2020-2034
• Figure 61. Asia Pacific Erectile Dysfunction Drugs Market (US$ Mn), by Online Pharmacies, 2020-2034
• Figure 62. Asia Pacific Erectile Dysfunction Drugs Market Analysis, By Country, 2020, 2024 and 2034
• Figure 63. Asia Pacific Erectile Dysfunction Drugs Market Attractiveness Analysis, By Country
• Figure 64. Latin America Erectile Dysfunction Drugs Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 65. Latin America Erectile Dysfunction Drugs Market Attractiveness Analysis, By Product Type
• Figure 66. Latin America Erectile Dysfunction Drugs Market (US$ Mn), by Branded Drugs, 2020-2034
• Figure 67. Latin America Erectile Dysfunction Drugs Market (US$ Mn), by Generic Drugs, 2020-2034
• Figure 68. Latin America Erectile Dysfunction Drugs Market Analysis, By Route of Administration, 2020, 2024 and 2034
• Figure 69. Latin America Erectile Dysfunction Drugs Market Attractiveness Analysis, By Route of Administration
• Figure 70. Latin America Erectile Dysfunction Drugs Market (US$ Mn), by Oral, 2020-2034
• Figure 71. Latin America Erectile Dysfunction Drugs Market (US$ Mn), by Injectable, 2020-2034
• Figure 72. Latin America Erectile Dysfunction Drugs Market (US$ Mn), by Topical, 2020-2034
• Figure 73. Latin America Erectile Dysfunction Drugs Market (US$ Mn), by Intraurethral Suppositories, 2020-2034
• Figure 74. Latin America Erectile Dysfunction Drugs Market Analysis, By Distribution Channel, 2020, 2024 and 2034
• Figure 75. Latin America Erectile Dysfunction Drugs Market Attractiveness Analysis, By Distribution Channel
• Figure 76. Latin America Erectile Dysfunction Drugs Market (US$ Mn), by Hospital Pharmacies, 2020-2034
• Figure 77. Latin America Erectile Dysfunction Drugs Market (US$ Mn), by Retail Pharmacies, 2020-2034
• Figure 78. Latin America Erectile Dysfunction Drugs Market (US$ Mn), by Online Pharmacies, 2020-2034
• Figure 79. Latin America Erectile Dysfunction Drugs Market Analysis, By Country, 2020, 2024 and 2034
• Figure 80. Latin America Erectile Dysfunction Drugs Market Attractiveness Analysis, By Country
• Figure 81. Middle East & Africa Erectile Dysfunction Drugs Market Analysis, By Product Type, 2020, 2024 and 2034
• Figure 82. Middle East & Africa Erectile Dysfunction Drugs Market Attractiveness Analysis, By Product Type
• Figure 83. Middle East & Africa Erectile Dysfunction Drugs Market (US$ Mn), by Branded Drugs, 2020-2034
• Figure 84. Middle East & Africa Erectile Dysfunction Drugs Market (US$ Mn), by Generic Drugs, 2020-2034
• Figure 85. Middle East & Africa Erectile Dysfunction Drugs Market Analysis, By Route of Administration, 2020, 2024 and 2034
• Figure 86. Middle East & Africa Erectile Dysfunction Drugs Market Attractiveness Analysis, By Route of Administration
• Figure 87. Middle East & Africa Erectile Dysfunction Drugs Market (US$ Mn), by Oral, 2020-2034
• Figure 88. Middle East & Africa Erectile Dysfunction Drugs Market (US$ Mn), by Injectable, 2020-2034
• Figure 89. Middle East & Africa Erectile Dysfunction Drugs Market (US$ Mn), by Topical, 2020-2034
• Figure 90. Middle East & Africa Erectile Dysfunction Drugs Market (US$ Mn), by Intraurethral Suppositories, 2020-2034
• Figure 91. Middle East & Africa Erectile Dysfunction Drugs Market Analysis, By Distribution Channel, 2020, 2024 and 2034
• Figure 92. Middle East & Africa Erectile Dysfunction Drugs Market Attractiveness Analysis, By Distribution Channel
• Figure 93. Middle East & Africa Erectile Dysfunction Drugs Market (US$ Mn), by Hospital Pharmacies, 2020-2034
• Figure 94. Middle East & Africa Erectile Dysfunction Drugs Market (US$ Mn), by Retail Pharmacies, 2020-2034
• Figure 95. Middle East & Africa Erectile Dysfunction Drugs Market (US$ Mn), by Online Pharmacies, 2020-2034
• Figure 96. Middle East & Africa Erectile Dysfunction Drugs Market Analysis, By Country, 2020, 2024 and 2034
• Figure 97. Middle East & Africa Erectile Dysfunction Drugs Market Attractiveness Analysis, By Country